H.A.M. Kooistra

Research

Publications
  1. CD47 Expression Defines the Efficacy of Rituximab in Non-Germinal Center B-Cell (non-GCB) Diffuse Large B-Cell Lymphoma (DLBCL)

    Van Meerten, T., Bouwstra, R., He, Y., Janneke, D. B., Kooistra, H., Fehrmann, R., Ammatuna, E., Huls, G. & Bremer, E., 29-Nov-2018, In : Blood. 132, Suppl.1, 3 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  2. Risk factors for venous thromboembolism in patients treated for differentiated thyroid carcinoma

    van der Boom, T., Hesselink, E. N. K., Kooistra, H. A. M., Meijer, K., van der Horst-Schrivers, A. N. A., Lefrandt, J. D. & Links, T. P., 1-Jun-2017, In : Endocrine-Related cancer. 24, 6, p. 267-273 7 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Risk of Bleeding and Thrombosis in Patients 70 Years or Older Using Vitamin K Antagonists

    Kooistra, H. A. M., Calf, A. H., Piersma - Wichers, G., Kluin-Nelemans, H. C., Izaks, G. J., Veeger, N. J. G. M. & Meijer, K., Aug-2016, In : Jama Internal Medicine. 176, 8, p. 1176-1183 8 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (14) »

View graph of relations

ID: 496331